Xylem (XYL) EBIAT (2016 - 2025)
Historic EBIAT for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $227.0 million.
- Xylem's EBIAT rose 460.83% to $227.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $948.0 million, marking a year-over-year increase of 1421.69%. This contributed to the annual value of $890.0 million for FY2024, which is 4614.12% up from last year.
- According to the latest figures from Q3 2025, Xylem's EBIAT is $227.0 million, which was up 460.83% from $226.0 million recorded in Q2 2025.
- In the past 5 years, Xylem's EBIAT registered a high of $326.0 million during Q4 2024, and its lowest value of $12.0 million during Q3 2022.
- Its 5-year average for EBIAT is $152.8 million, with a median of $149.0 million in 2022.
- Its EBIAT has fluctuated over the past 5 years, first crashed by 8947.37% in 2022, then soared by 116666.67% in 2023.
- Quarter analysis of 5 years shows Xylem's EBIAT stood at $113.0 million in 2021, then surged by 31.86% to $149.0 million in 2022, then soared by 78.52% to $266.0 million in 2023, then grew by 22.56% to $326.0 million in 2024, then crashed by 30.37% to $227.0 million in 2025.
- Its EBIAT was $227.0 million in Q3 2025, compared to $226.0 million in Q2 2025 and $169.0 million in Q1 2025.